Ancillary therapy of bovine respiratory disease.
Ancillary therapy for bovine respiratory disease is covered with an emphasis on anti-inflammatories. Theoretic rationale and any available clinical data are reviewed for glucocorticosteroids as well as nonsteroidal anti-inflammatory drugs such as phenylbutazone, flunixin meglumine, and aspirin. Antihistamines, immunomodulators, diuretics, and bronchodilators are also discussed.
Apley
M
M
Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, USA.
D000276:Adjuvants, Immunologic / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy* / Q000191:economics; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006634:Histamine H1 Antagonists / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use*; D012140:Respiratory Tract Diseases / Q000188:drug therapy / Q000191:economics / Q000662:veterinary*
D000276:Adjuvants, Immunologic; D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists